October 2012 Issue of MMM
October 2012 issue
There is no way that each year more than a third of the industry is job hunting
The job cuts haven't stopped. But here's the good news: average salaries are up, job satisfaction is holding steady, and execs seem to be valuing ...
What if analytics could help predict when one of your staffers needs a growth test, a new career-path option or just some coaching? Tanya Lewis ...
Seek the next rung. Take the plunge. Most of all, these eight senior healthcare execs advise, enjoy the ride. As told to Marc Iskowitz
How can Marketing and Managed Markets evolve an already complex relationship to meet the new demands of payers? Our expert panel, led by James Chase, ...
Andy Schmeltz, President, US Oncology Business Unit, Pfizer
Prescribing remains important, but it's half the picture: pharma's ultimate customer is the patient
On the whole, Ambien and the other medicines in its group are well tolerated and help many people
A Bernstein Research report shows that, essentially, "Pipeline success rates across all phases of development have been slowly worsening or at best staying flat, depending ...
The drug industry may be shifting its attention to specialty drugs, but data shows that detailing pressure and pharmaceutical rep access are still much higher ...
Pharmacists are the latest recruits in the government's push to reduce the nation's risk of heart disease.
News on Content Marketing Institute, MedCityNews.com, Sanofi and the FDA
Med Ed Report
Only 35% of physicians are aware of the FDA's class-wide safety plan for extended-release and long-acting opioids, a survey showed.
A physician survey found that docs are reconsidering their participation in industry-sponsored CME, fearful that their inclusion in Sunshine Act databases as having received payments ...
As part of a $181-million settlement with states to resolve charges of improper marketing and advertising, Johnson & Johnson agreed to stop several practices regarding ...
News on New England Journal of Medicine, MedBiquitous, Physicians' Education Resource, CECity and CBI
The size of JAMA's audience is giving the Super Bowl a run for its money
Health marketing communications firm Enspektos did a deep dive into desktop and media habits and found that who you are in the healthcare industry plays ...
News on Wolters Kluwer, Contraception magazine, the Crohn's and Colitis Foundation and Elsevier
Many media agencies now use pay-for-performance compensation. It calls for tying media efforts to trackable metrics. What metrics should be used, and how can an ...
WebMD executed a cross-platform magazine redesign with a more visual and celeb-centric new look. It's the first refresh for WebMD the Magazine since its debut ...
A new tool on MedPageToday.com promises to streamline the research process for physicians. Called the Oncology Next Tool, it can deliver patient-focused information just by ...
News on Doximity, Eli Lilly and InTouch Solutions
A study of advertising for drugs that have made the switch from prescription to over-the-counter status found that the presentation of risk information plummeted once ...
Eli Lilly's commitment to the positioning and branding for Cialis has remained refreshingly consistent
Merck and ESPN's Mike Golic kicked off a diabetes education program in August to offer patients help navigating a type-2 diabetes diagnosis.
Budgets of pharmaceutical marketing research teams are starting to recover, one analyst firm found.
Healthcare marketing research firm WorldOne expanded its board of directors with the addition of Kerry Hicks, the founder and former CEO of HealthGrades
The healthcare communications arm of Publicis Group is bringing two of its digital agencies together in a move designed to bolster them against the tide ...
Draftfcb Healthcare has bought Tarrytown, NY-based drug marketing shop Hudson Global.
News on Roska Healthcare Advertising, Pacific Communications, Havas Worldwide Health and Rosetta
Part D is the Michael Phelps of healthcare reform—providing a roadmap toward real evolution
Used for the first time in the recent $3 billion healthcare fraud settlement with GlaxoSmithKline (GSK), a new enforcement tool has joined the federal government's ...
The American people are still trying to get their heads around what the Affordable Care Act means to them
Ads that engage and hold a patient employ the 3 P's: Personification, Personalization, and Projection.
Gabrielle Pastore, Global Strategic Commercial Innovation Vice President, Cadient Group
At Work With
Rick Conrad, Associate Creative Director/Art, AbelsonTaylor
Name That Brand
Project timelines that were once measured in months are now compressed into days
- Sunovion hires former BI exec as VP of marketing
- Five things for pharma marketers to know: Thursday, October 20, 2016
- Five things for pharma marketers to know: Monday, October 24, 2016
- Five things for pharma marketers to know: Wednesday, October 19, 2016
- Five things for pharma marketers to know: Tuesday, October 25, 2016
- Merck educates doctors about biosimilars, long before it will sell one in the U.S.
- 4 trends with the potential to change behavior in the patient journey
- 2016 Pharma Report: All the data in one place
- What do physicians think about biosimilars?
- Novartis considers new sales model for experimental cancer therapy